research 0282 Effect of systemic immunomodulators on incidence of alopecia areata: A retrospective cohort study
Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.
Search
forResearch
5 / 1000+ results
research Baricitinib (Olumiant)
This CADTH recommendation advises that Olumiant should be publicly reimbursed for treating severe alopecia areata in adults, provided conditions such as a 50% scalp hair loss and specific prescribing criteria are met.
research Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
This systematic review reports that "COVID toes" and other skin manifestations can be initial signs of COVID-19, and advises immunosuppressive therapy adjustments only for infected or at-risk patients.
research The promise and challenges of cell therapy for psoriasis*
In this review, the authors discuss the potential for cell therapy, such as hematopoietic stem cell transplantation and mesenchymal stromal cells, to treat severe psoriasis unresponsive to biological therapies, while highlighting the associated risks, costs, and regulatory challenges.
research Managing Skin Diseases that Flare During Pregnancy and in the Postpartum period: Part 2- Management & Safety Considerations
Managing skin diseases during pregnancy and postpartum requires careful consideration of treatment safety and dosing to protect both mother and baby.
Learn
2 / 801 resultslearn Neem Oil
natural substance from Neem tree with medicinal and pesticidal properties
learn microbiota modulator
Community Join
2 / 1000+ resultscommunity HMI-115 update: Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia
Chime Biologics and Hope Medicine are speeding up the launch of a first-in-class antibody drug, HMI-115, for endometriosis and androgenic alopecia. The treatment involves a series of subcutaneous injections, has shown promising results in phase 1, and continues to promote hair regrowth even after the treatment is stopped.
community Why hasn’t anyone made a "DHT sponge" biologic yet???
The conversation discusses the potential for developing a biologic "DHT sponge" to neutralize DHT in the bloodstream as a treatment for hair loss, suggesting it could be more targeted and have fewer side effects than current treatments like finasteride and dutasteride. Concerns include the complexity, cost, and potential side effects of such a treatment, as well as skepticism about its feasibility and market interest.
Clinics
6 / 9 results- 20Hair SystemsBoise Biologics Regenerative MedicineBoise, ID · US
- 33Hair Loss TreatmentsMotus Biologics and Sports MedicineOverland Park, KS · US
- 15Hair Loss TreatmentsRestore Biologics - Hair Preservation and Restoration SpecialistsSan Diego, CA · US
- 16Hair TransplantClinica Medicina Estetica-Biologica BoadillaMadrid, Madrid · ES
- 49
Hair Loss TreatmentsTrycholog Toruń Instytut Zdrowego Włosa Biologica Maria GurtowskaToruń · PL - 21Hair Loss TreatmentsDr. McKenna's Orthopedics & BiologicsTrophy Club, TX · US
Experts
— no results